Overview

	Volume	Price	Change
AGP	0	25.90	0.00%
BCP	0	9.70	0.00%
BIO	0	20.70	0.00%
CDP	0	11.70	0.00%
CNC	0	28.50	0.00%
DBD	0	38.30	0.00%
DBM	0	36.90	0.00%
DBT	0	11.10	0.00%
DCL	0	24.05	0.00%

Health Care > Pharmaceuticals

My Favorite Quotes

Symbol		Last	Change

DHT 40.00 0.00%

23/11

Pharmaceutical firms report positive results in Q3Vietnamnews

01/12

DHT: Notice of record date for cash dividend paymentHNX

Clear all recent quotes

Market Update

Last updated at 9:05:00 AM

VN-INDEX

1,040.54

0.00/0.00%

Market Overview

Company Research

Type in the symbol above for thorough background information, key statistics and financial information.

Stock Sectors

Basic	40.00
Open	0.00
Average	40.00
Day's Range	0.00 - 0.00
Volume	0
52-Week Range	36.90 - 44.30
Avg Volume (10 days)	11,830
Market Cap	1056.29 bil
Shares Outstanding	26.41 mil
P/E	11.09x

Real-time Streaming Quotes

Today 7 Day 1 Month 3 Month 6 Month 1 Year 10 Year

Create Alert at: 38 42 44 ...

Financial Info

Financial Highlights | Ratios

Valuation

P/E	11.09x
P/S	0.57x
P/B	1.32x
EPS	3605.49

Financial Strength

Quick Ratio (MRQ)	0.98x
Current Ratio (MRQ)	1.80x
Total Debt/Equity (MRQ)	0.84x
Total Debt/Assets (MRQ)	0.46x

Operating Ratios

Assets Turnover (TTM)	1.36x
Inventory Turnover (TTM)	4.12x
Receivables Turnover (TTM)	5.96x

Profitability

Gross Margin (TTM)	10.19%
Operating Margin (TTM)	6.21%
EBIT Margin (TTM)	6.71%
Profit Margin (TTM)	5.39%

Management Effectiveness

ROA (TTM)	7.31%
ROE (TTM)	12.75%
ROIC (TTM)	9.88%

Growth Rate

Diluted EPS Growth (TTM)	39.00%
Sales Growth (TTM)	14.17%
Profit Growth (TTM)	38.63%
Asset Growth (TTM)	2.89%

MRQ: Most Recent Quarter TTM: Trailing 12 Mon. LFY: Last Fiscal Year

News

Company News

Other Related News

23/11	Pharmaceutical firms report positive results in Q3 - Vietnamnews
01/12	DHT: Notice of record date for cash dividend payment - HNX
25/11	DHT: Board Resolution - HNX
20/10	DHT: Financial Statement Quarter 3/2020 (holding company) - HNX
20/10	DHT: Financial Statement Quarter 3/2020 - HNX
16/09	DHT: Board Resolution - HNX
04/09	DHT: Extraordinary General Mandate 2020 - HNX
21/08	DHT: Notice of holding the Extraordinary General Meeting of Shareholders of 2020 - HNX
07/08	DHT: Reviewed financial statement 2020 (holding company) - HNX
07/08	DHT: Reviewed financial statement 2020 - HNX
28/07	DHT: Corporate Governance Report (first 06 months) - HNX
27/07	DHT: Notice of record date for Extraordinary General Meeting of Shareholders 2020 - HNX
23/07	DHT: Approve holding the Extraordinary General Meeting of Shareholders 2020 - HNX
20/07	DHT: Financial Statement Quarter 2/2020 (holding company) - HNX
20/07	DHT: Financial Statement Quarter 2/2020 - HNX

More News

Upcoming Events

There is no event.

More...

Company Profile

Hatay Pharmaceutical Joint Stock Company (Hataphar) is a Vietnam-based pharmaceutical company. It is engaged in the manufacturing, marketing, wholesale and retail trading, import and export of pharmaceutical products, preparations and materials, vaccines, along with medical equipment and supplies. The Company also manufactures and trades cosmetic products, supplemental food, general chemicals...

Headquarters

10 Quang Trung Street, Ha Dong TownHanoi,

Shares Outstanding	26.41 mil
Assets	1,469.50 bil
Equity	798.84 bil
Market Cap	1,056.29 bil
Employees	781
Branches	14
Industry	Pharmaceuticals
Web Address	www.hataphar.com.vn

Full Profile

We continuously improve our services, here are the latest updates...

Portfolio

Allow you to monitor a customised group of securities. You can set up multiple Portfolios to help you better manage your investments.

Trigger Alerts

Get up-to-date alerts delivered directly to your email address.

Stock Screener

Allow you to filter the market and find exactly what sort of company you are looking for.

Live Terminal

Get instant access to FREE REAL-TIME streaming quotes for hundreds of stocks from HOSE, HNX and UPCOM exchanges.